Lilly's weight loss drug cuts diabetes risk by 94% in three-year trial, company says
Source: TodayFeedsMedia
Eli Lilly’s weight loss drug cut the risk of developing Type 2 diabetes by 94% in prediabetic adults who were overweight or obese after three years of weekly injections, the company disclosed in a statement on Tuesday. The Indianapolis, Indiana-based... [1600 chars]
